by Baylor College of MedicineCredit: CC0 Public DomainAlzheimer's disease (AD), the most common type of dementia, progressively impairs memory, concentration and the ability to learn new thin
by Baylor College of MedicineCredit: CC0 Public DomainAlzheimer's disease (AD), the most common type of dementia, progressively impairs memory, concentration and the ability to learn new thin
byThe Mount Sinai HospitalAccumulation of extracellular matrix content in brain of TIMP2-deficient "KO" mice (left column) that leads to impaired plasticity processes, including the mi
byThe Mount Sinai HospitalAccumulation of extracellular matrix content in brain of TIMP2-deficient "KO" mice (left column) that leads to impaired plasticity processes, including the mi
by VIB (the Flanders Institute for Biotechnology)A 3D visualization of lectin-stained blood vessels (magenta) and Thioflavin-S–positive (yellow) amyloid plaques in the brain of a mouse model of A
by VIB (the Flanders Institute for Biotechnology)A 3D visualization of lectin-stained blood vessels (magenta) and Thioflavin-S–positive (yellow) amyloid plaques in the brain of a mouse model of A
byDrexel UniversityEPOC X Electrode Montage (adapted from Williams et al., 2023). Credit:Frontiers in Neuroergonomics(2024). DOI: 10.3389/fnrgo.2024.1340732As people age, their brain
byDrexel UniversityEPOC X Electrode Montage (adapted from Williams et al., 2023). Credit:Frontiers in Neuroergonomics(2024). DOI: 10.3389/fnrgo.2024.1340732As people age, their brain
byColumbia UniversityMicroscope image of a fly brain (gray) with magenta visual neurons connecting to a motor neuron in this study (green). Credit: Stephen Huston, Zuckerman Institute; Rebecca J
byColumbia UniversityMicroscope image of a fly brain (gray) with magenta visual neurons connecting to a motor neuron in this study (green). Credit: Stephen Huston, Zuckerman Institute; Rebecca J
by University of WaterlooCredit: Pixabay/CC0 Public DomainNew research has found that people with mild cognitive impairment may not inevitably develop dementia and, in fact, having higher educati
by University of WaterlooCredit: Pixabay/CC0 Public DomainNew research has found that people with mild cognitive impairment may not inevitably develop dementia and, in fact, having higher educati
by Tufts UniversityCredit: CC0 Public DomainOlder adults who consumed small amounts of flavonoid-rich foods, such as berries, apples and tea, were two to four times more likely to develop Alzheim
by Tufts UniversityCredit: CC0 Public DomainOlder adults who consumed small amounts of flavonoid-rich foods, such as berries, apples and tea, were two to four times more likely to develop Alzheim
by Aarhus UniversityLarge Aβ Agg [+] MCI patients display lower AD-like brain pathology than large Aβ Agg [-] MCI.a18F-FTP PET uptake in each group at baseline, two-year follow-up, an
by Aarhus UniversityLarge Aβ Agg [+] MCI patients display lower AD-like brain pathology than large Aβ Agg [-] MCI.a18F-FTP PET uptake in each group at baseline, two-year follow-up, an
by Will Doss,Northwestern UniversityThe interaction between APP (red) and GAG (green) in the cell. Credit: Northwestern UniversityFor the first time, scientists have identified and inhibited a m
by Will Doss,Northwestern UniversityThe interaction between APP (red) and GAG (green) in the cell. Credit: Northwestern UniversityFor the first time, scientists have identified and inhibited a m
by The National Institutes for Quantum Science and TechnologyFig. 1. Neurodegenerative processes in rTg4510 mice are accelerated by an LPD and ameliorated by Amino LP7.(A) Schematic diagram of the exp
by The National Institutes for Quantum Science and TechnologyFig. 1. Neurodegenerative processes in rTg4510 mice are accelerated by an LPD and ameliorated by Amino LP7.(A) Schematic diagram of the exp
by Diana Yates,University of Illinois at Urbana-ChampaignWhen tested in a mouse model of Alzheimer's disease, a new compound, L1, reduced neuroinflammation, amyloid plaques and other molecul
by Diana Yates,University of Illinois at Urbana-ChampaignWhen tested in a mouse model of Alzheimer's disease, a new compound, L1, reduced neuroinflammation, amyloid plaques and other molecul